Ontology highlight
ABSTRACT:
INSTRUMENT(S): Illumina HiSeq 2000
ORGANISM(S): Mus musculus
SUBMITTER: Tao Xie
PROVIDER: E-MTAB-2510 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
Belmont Peter J PJ Jiang Ping P McKee Trevor D TD Xie Tao T Isaacson Jason J Baryla Nicole E NE Roper Jatin J Sinnamon Mark J MJ Lee Nathan V NV Kan Julie L C JL Guicherit Oivin O Wouters Bradly G BG O'Brien Catherine A CA Shields David D Olson Peter P VanArsdale Todd T Weinrich Scott L SL Rejto Paul P Christensen James G JG Fantin Valeria R VR Hung Kenneth E KE Martin Eric S ES
Science signaling 20141111 351
Targeted blockade of aberrantly activated signaling pathways is an attractive therapeutic strategy for solid tumors, but drug resistance is common. KRAS is a frequently mutated gene in human cancer but remains a challenging clinical target. Inhibitors against KRAS signaling mediators, namely, PI3K (phosphatidylinositol 3-kinase) and mTOR (mechanistic target of rapamycin), have limited clinical efficacy as single agents in KRAS-mutant colorectal cancer (CRC). We investigated potential bypass mech ...[more]